Sensus Healthcare的动态

Cutaneous T-cell lymphoma (CTCL) presents unique challenges that require a patient-focused approach to improve care and outcomes. But how can dermatologists and healthcare professionals collaborate to enhance care for CTCL patients? Dr. Larisa J. Geskin, Professor of Dermatology at Columbia University Medical Center, reviews the recommendations from a global consensus statement. She discusses how dermatologists can foster stronger multidisciplinary collaboration and adopt patient-centric strategies to address the complexities of CTCL care. Join the conversation on reshaping the future of CTCL care: https://ow.ly/7aYj50Tku2N #Dermatology #CTCL #PatientCare #HealthcareInnovation #MedicalEducation #Oncology

?? COLLABORATION IS VITAL: Advanced #skincancer treatment benefits greatly from partnerships between dermatologists and oncologists. Practical Dermatology Chief Medical Editor Dr. Neal Bhatia and Dr. Todd Schlesinger, a dermatologist and Practical Dermatology Editorial Board member, share their insights on the importance of teamwork as #immunotherapy technology advances. Check out the full discussion here: https://ow.ly/OzMp50STXww #dermatology #oncology

Learn about the types of non-melanoma skin cancers, potential treatments and side effects, clinical trials and the emotional concerns of a diagnosis from a Mindful Dermatology Physicians Assistant. Please register by May 7 here: https://lnkd.in/gE7NbYpz

A new publication in the Journal of Clinical and Aesthetic Dermatology (JCAD) highlights multidisciplinary consensus guidelines that recommend combining traditional staging with DecisionDx-SCC (40-GEP) to improve treatment recommendations, including the use of ART. The panel members agreed that the addition of DecisionDx-SCC testing has significant clinical utility in: -Escalation of care for lower-stage patients with high-risk tumors -De-escalation of care for patients for whom the risks of ART may outweigh the benefits -Decision-making regarding elective radiation to the nodal basin Read “Integrating 40-GEP Testing to Improve Clinical Recommendations for Adjuvant Radiation for Cutaneous Squamous Cell Carcinoma” here for more details: https://hubs.la/Q02rnpgC0

Today is European Skin Cancer Prevention Day! A day to raise awareness, as leaders in dermatology, about the effects of skin cancer. Skin cancer, diagnosed in its earliest stages, can exponentially increase long-term survival rates in patients. It is our duty, as professionals in the field, to help prevent its incidence. At ISD, we offer a comprehensive platform to all professionals in the dermatology field, ensuring they stay informed about industry advancements and incorporate cutting-edge insights into their practice. #ISD #InternationalSchoolDerma #EuropeanSkinCancerPreventionDay

The September issue of the American Journal of Clinical Dermatology is now online. See articles on: * Systemic Therapy of Metastatic Uveal Melanoma * Human Inborn Errors of Immunity in Pyoderma Gangrenosum * Management of Melasma * Lichen Planus: Diagnosis and Treatment * Hidradenitis Suppurativa: New Targets and Emerging Treatments * Hedgehog Pathway Inhibitors in Advanced Basal Cell Carcinoma * Sequencing of Targeted Therapy in Psoriasis * Dapsone Use in Dermatology * Noninvasive Skin Imaging Techniques in Acne Scars * Brodalumab for Palmoplantar Pustulosis https://lnkd.in/gupVcHSw

?? ?????? ???????? #???????????????????????????????????????? ???????? ???? ?????????????????? ???????? ???? ??????????????????????? In recent decades, the development of novel and highly specific therapeutics has increased a lot in dermatology, especially for conditions such as melanoma, psoriasis, and eczema. However, diagnostic techniques have not advanced at the same pace, preventing highly specific therapeutics from reaching their full potential. This large gap between diagnostics and therapeutics is being bridged by DNA- and RNA-based molecular diagnostics. Dermagnostix started on building this bridge with #PsorX – the worldwide first molecular test for the differential diagnosis of psoriasis and eczema! You want to join our journey of #MovingDiagnosticFrontiers in dermatology? Subscribe to our #newsletter: https://lnkd.in/eRCXcTVB #BeyondTheSurface #Psoriasis #Eczema

Long-term clinical trial results from a JAK inhibitor in #AlopeciaAreata (AA) patients, which includes integrated efficacy (through 104 weeks) and safety (up to 3.6 years) data, are published in the Journal of the European Academy of Dermatology and Venereology. Learn about long-term treatment results of severe AA with a JAK inhibitor in this manuscript: https://e.lilly/3SV3OD3

It was such a pleasure to present the new aspects in the systemic treatment of cutaneous squamous cell carcinoma at the Swiss Congress of Dermatology #SGDV #Dermatooncology

Ophthopedia Update:Blastic Plasmacytoid Dendritic Cell Neoplasm with ocular infiltration: A 62-year-old male patient presented to the Dermatology clinic with a 6-month history of progressive nodulo-tumoral skin lesions (Figure 1) and cytopenias. He had an elevated subconjunctival mass next to the caruncle of the left eye measuring approximately 1cm at its largest extension clinically similar to skin lesions (Figure 2). Skin biopsy was performed and showed a dense dermal infiltrate composed of blast-like cells (Figure 3) that were positive on immunohistochemistry for CD123, CD4 and CD56. #Ophthalmology #Ophthotwitter #Scicomm